Article info
Rheumatoid arthritis
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
- Correspondence to Dr Andreas Kerschbaumer, Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria; andreas.kerschbaumer{at}meduniwien.ac.at
Citation
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Publication history
- Received September 15, 2022
- Accepted October 10, 2022
- First published November 11, 2022.
Online issue publication
January 03, 2023
Article Versions
- Previous version (11 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.